Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Patel Mona Chetan Insider Profile
4 Followers
Patel Mona Chetan, Director at Envoy Medical, holds 5.00K shares in Envoy Medical (Ticker: COCH). Most recently, Patel Mona Chetan Bought $5,000 shares of Envoy Medical on Sep 11, 2024 for an estimated value of 16.52K.
Patel Mona Chetan has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Patel Mona Chetan's holdings
Insider Roles
Director
Roles that Patel Mona Chetan holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Patel Mona Chetan
Patel Mona Chetan's Trading History
List of latest transactions for each holding click on a transaction to see Patel Mona Chetan's performance on stock
You May Also Like
Patel Mona Chetan insider profile FAQ
What is the percentage of profitable transactions made by Patel Mona Chetan?
The percentage of profitable transactions made by Patel Mona Chetan is ―.
What is the average return per transaction made by Patel Mona Chetan?
The average return per transaction made by Patel Mona Chetan is ―.
What stocks does Patel Mona Chetan hold?
Patel Mona Chetan holds: COCH stocks.
What was Patel Mona Chetan’s latest transaction?
Patel Mona Chetan latest transaction was an Informative Buy of $16.52K.
What was Patel Mona Chetan's most profitable transaction?
Patel Mona Chetan’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Patel Mona Chetan's role in Envoy Medical?
Patel Mona Chetan's role in Envoy Medical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.